Voleon Capital Management’s Eli Lilly LLY Stock Holding History

Voleon Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63.9M	Sell	53,311 -20,365	-28%	-$20.8M	1.17%	13
2026 Q1	$67.8M	Buy	73,676 +33,146	+82%	+$33.6M	1.46%	8
2025 Q4	$43.6M	Buy	40,530 +24,565	+154%	+$23.5M	0.94%	12
2025 Q3	$12.2M	Sell	15,965 -3,051	-16%	-$2.27M	0.3%	66
2025 Q2	$14.8M	Buy	19,016 +9,263	+95%	+$7.2M	0.81%	18
2025 Q1	$8.06M	Buy	9,753 +2,415	+33%	+$2.01M	0.63%	39
2024 Q4	$5.66M	Buy	+7,338	New	+$6.08M	0.42%	60
2019 Q3	–	Sell	-62,000	Closed	-$6.87M	–	205
2019 Q2	$6.87M	Buy	+62,000	New	+$7.3M	0.39%	59

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Voleon Capital Management's LLY Position: Q2 2026 in Review

Voleon Capital Management reduced its Eli Lilly (LLY) stake by 28% in Q2 2026, selling an estimated $20.8M and leaving 53,311 shares worth $63.9M. The position accounts for 1.17% of the portfolio, ranked #13.

Voleon Capital Management first reported a position in LLY in Q2 2019 and has held it in 8 quarters since. The position peaked at $67.8M in Q1 2026. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Voleon Capital Management held 53,311 shares of Eli Lilly worth $63.9M as of Q2 2026.
Voleon Capital Management sold 20,365 Eli Lilly shares in Q2 2026, an estimated $20.8M.
Eli Lilly made up 1.17% of Voleon Capital Management's portfolio in Q2 2026, its #13 holding.
Voleon Capital Management first reported a position in Eli Lilly in Q2 2019 and has held it in 8 quarters since.
Voleon Capital Management's Eli Lilly position peaked at $67.8M in Q1 2026.
4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.